{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:46:07Z","timestamp":1791891967826,"version":"4.3.4"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T00:00:00Z","timestamp":1599782400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA043412"],"award-info":[{"award-number":["K01DA043412"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P30AI042853"],"award-info":[{"award-number":["P30AI042853"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007161","name":"Boston University","doi-asserted-by":"crossref","award":["BU Peter Paul Career Development Professorship"],"award-info":[{"award-number":["BU Peter Paul Career Development Professorship"]}],"id":[{"id":"10.13039\/100007161","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11606-020-06201-6","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T13:02:58Z","timestamp":1599829378000},"page":"129-137","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["\u201cHealth Is on the Back Burner:\u201d Multilevel Barriers and Facilitators to Primary Care Among People Who Inject Drugs"],"prefix":"10.1007","volume":"36","author":[{"given":"Delia","family":"Motavalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo K.","family":"Valente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Salhaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Olson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dea L.","family":"Biancarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Edeza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel J.","family":"Earlywine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon D. L.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari-Lynn","family":"Drainoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Mimiaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie B.","family":"Biello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6828-1919","authenticated-orcid":false,"given":"Angela R.","family":"Bazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,11]]},"reference":[{"issue":"12","key":"6201_CR1","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1016\/S2214-109X(17)30375-3","volume":"5","author":"L Degenhardt","year":"2017","unstructured":"Degenhardt L, Peacock A, Colledge S, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Heal. 2017;5(12):e1192-e1207. doi:https:\/\/doi.org\/10.1016\/S2214-109X(17)30375-3","journal-title":"Lancet Glob Heal."},{"key":"6201_CR2","doi-asserted-by":"publisher","unstructured":"Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and Opioid-Involved Overdose Deaths \u2014 United States, 2013\u20132017. Morb Mortal Wkly Rep. 2018;67(5152). https:\/\/doi.org\/10.15585\/mmwr.mm6751521e1","DOI":"10.15585\/mmwr.mm6751521e1"},{"issue":"2","key":"6201_CR3","doi-asserted-by":"publisher","first-page":"102","DOI":"10.2471\/BLT.12.108282","volume":"91","author":"BM Mathers","year":"2013","unstructured":"Mathers BM, Degenhardt L, Bucello C, Lemon J, Wiessing L, Hickman M. Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ. 2013;91(2):102-123. doi:https:\/\/doi.org\/10.2471\/BLT.12.108282","journal-title":"Bull World Health Organ."},{"issue":"3","key":"6201_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1086\/313703","volume":"30","author":"IA Binswanger","year":"2000","unstructured":"Binswanger IA, Kral AH, Bluthenthal RN, Rybold DJ, Edlin BR. High Prevalence of Abscesses and Cellulitis Among Community-Recruited Injection Drug Users in San Francisco. Clin Infect Dis. 2000;30(3):579-581. doi:https:\/\/doi.org\/10.1086\/313703","journal-title":"Clin Infect Dis."},{"key":"6201_CR5","unstructured":"HIV Among People Who Inject Drugs. Centers for Disease Control and Prevention. Available at: https:\/\/www.cdc.gov\/hiv\/group\/hiv-idu.html. Published March 15, 2020. ."},{"key":"6201_CR6","unstructured":"Surveillance for Viral Hepatitis \u2013 United States, 2017. Center for Disease Control and Prevention (CDC). Available at: https:\/\/www.cdc.gov\/hepatitis\/statistics\/2017surveillance\/index.htm. Published 2019. Accessed February 18, 2020."},{"issue":"5","key":"6201_CR7","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/archpsyc.64.5.566","volume":"64","author":"WM Compton","year":"2007","unstructured":"Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64(5):566-576. doi:https:\/\/doi.org\/10.1001\/archpsyc.64.5.566","journal-title":"Arch Gen Psychiatry."},{"issue":"3","key":"6201_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.addbeh.2013.11.022","volume":"39","author":"EM Goldner","year":"2014","unstructured":"Goldner EM, Lusted A, Roerecke M, Rehm J, Fischer B. Prevalence of Axis-1 psychiatric (with focus on depression and anxiety) disorder and symptomatology among non-medical prescription opioid users in substance use treatment: Systematic review and meta-analyses. Addict Behav. 2014;39(3):520-531. doi:https:\/\/doi.org\/10.1016\/j.addbeh.2013.11.022","journal-title":"Addict Behav."},{"issue":"2","key":"6201_CR9","first-page":"109","volume":"99","author":"AJ Visconti","year":"2019","unstructured":"Visconti AJ, Sell J, Greenblatt AD. Primary Care for Persons Who Inject Drugs. Am Fam Physician. 2019;99(2):109-116.","journal-title":"Am Fam Physician."},{"issue":"1","key":"6201_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12879-015-0913-0","volume":"15","author":"P Azar","year":"2015","unstructured":"Azar P, Wood E, Nguyen P, et al. Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: a longitudinal analysis. BMC Infect Dis. 2015;15(1):193. doi:https:\/\/doi.org\/10.1186\/s12879-015-0913-0","journal-title":"BMC Infect Dis."},{"issue":"44","key":"6201_CR11","doi-asserted-by":"publisher","first-page":"7846","DOI":"10.3748\/wjg.v19.i44.7846","volume":"19","author":"M Zeremski","year":"2013","unstructured":"Zeremski M, Zibbell JE, Martinez AD, Kritz S, Smith BD, Talal AH. Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care. World J Gastroenterol. 2013;19(44):7846-7851. doi:https:\/\/doi.org\/10.3748\/wjg.v19.i44.7846","journal-title":"World J Gastroenterol."},{"issue":"1","key":"6201_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1472-6874-14-5","volume":"14","author":"A Olsen","year":"2014","unstructured":"Olsen A, Banwell C, Madden A. Contraception, punishment and women who use drugs. BMC Womens Health. 2014;14(1):5. doi:https:\/\/doi.org\/10.1186\/1472-6874-14-5","journal-title":"BMC Womens Health."},{"issue":"5","key":"6201_CR13","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.contraception.2017.07.167","volume":"96","author":"AK Matusiewicz","year":"2017","unstructured":"Matusiewicz AK, Melbostad HS, Heil SH. Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder. Contraception. 2017;96(5):365-369. doi:https:\/\/doi.org\/10.1016\/j.contraception.2017.07.167","journal-title":"Contraception."},{"issue":"2","key":"6201_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jsat.2010.08.011","volume":"40","author":"SH Heil","year":"2011","unstructured":"Heil SH, Jones HE, Arria A, et al. Unintended pregnancy in opioid-abusing women. J Subst Abuse Treat. 2011;40(2):199-202. doi:https:\/\/doi.org\/10.1016\/j.jsat.2010.08.011","journal-title":"J Subst Abuse Treat."},{"issue":"Suppl 2","key":"6201_CR15","doi-asserted-by":"publisher","first-page":"S176","DOI":"10.1097\/QAI.0000000000000659","volume":"69","author":"J Iversen","year":"2015","unstructured":"Iversen J, Page K, Madden A, Maher L. HIV, HCV, and health-related harms among women who inject drugs: Implications for prevention and treatment. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S176-S181. doi:https:\/\/doi.org\/10.1097\/QAI.0000000000000659","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"24","key":"6201_CR16","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1016\/j.vaccine.2015.04.019","volume":"33","author":"MG Collier","year":"2015","unstructured":"Collier MG, Drobeniuc J, Cuevas-Mota J, Garfein RS, Kamili S, Teshale EH. Hepatitis A and B among young persons who inject drugs-Vaccination, past, and present infection. Vaccine. 2015;33(24):2808-2812. doi:https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.019","journal-title":"Vaccine."},{"issue":"2","key":"6201_CR17","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s11121-014-0500-4","volume":"16","author":"AA Al-Tayyib","year":"2015","unstructured":"Al-Tayyib AA, Thiede H, Burt RD, Koester S. Unmet Health Care Needs and Hepatitis C Infection Among Persons Who Inject Drugs in Denver and Seattle, 2009. Prev Sci. 2015;16(2):330-340. doi:https:\/\/doi.org\/10.1007\/s11121-014-0500-4","journal-title":"Prev Sci."},{"issue":"22","key":"6201_CR18","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1001\/jama.2019.16196","volume":"322","author":"RL Epstein","year":"2019","unstructured":"Epstein RL, Wang J, Hagan L, et al. Hepatitis C Virus Antibody Testing among 13- to 21-Year-Olds in a Large Sample of US Federally Qualified Health Centers. JAMA. 2019;322(22):2245-2248. doi:https:\/\/doi.org\/10.1001\/jama.2019.16196","journal-title":"JAMA."},{"issue":"Suppl 4","key":"6201_CR19","doi-asserted-by":"publisher","first-page":"S305","DOI":"10.2105\/AJPH.2018.304788","volume":"108","author":"W Garner","year":"2018","unstructured":"Garner W, Wilson BM, Beste L, Maier M, Ohl ME, Van Epps P. Gaps in preexposure prophylaxis uptake for HIV prevention in the Veterans Health Administration. Am J Public Health. 2018;108(Suppl 4):S305-S310. doi:https:\/\/doi.org\/10.2105\/AJPH.2018.304788","journal-title":"Am J Public Health."},{"key":"6201_CR20","doi-asserted-by":"publisher","unstructured":"McFarland W, Lin J, Santos GM, Arayasirikul S, Raymond HF, Wilson E. Low PrEP Awareness and Use Among People Who Inject Drugs, San Francisco, 2018. AIDS Behav. September 2019:1-4. doi:https:\/\/doi.org\/10.1007\/s10461-019-02682-7","DOI":"10.1007\/s10461-019-02682-7"},{"issue":"10","key":"6201_CR21","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1176\/ps.62.10.pss6210_1194","volume":"62","author":"FW Chi","year":"2011","unstructured":"Chi FW, Parthasarathy S, Mertens JR, Weisner CM. Continuing Care and Long-Term Substance Use Outcomes in Managed Care: Early Evidence for a Primary Care-Based Model. Psychiatr Serv. 2011;62(10):1194-1200. doi:https:\/\/doi.org\/10.1176\/ps.62.10.pss6210_1194","journal-title":"Psychiatr Serv."},{"issue":"2","key":"6201_CR22","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.idc.2018.02.012","volume":"32","author":"SN Facente","year":"2018","unstructured":"Facente SN, Burk K, Eagen K, Mara ES, Smith AA, Lynch CS. New Treatments Have Changed the Game: Hepatitis C Treatment in Primary Care. Infect Dis Clin North Am. 2018;32(2):313-322. doi:https:\/\/doi.org\/10.1016\/j.idc.2018.02.012","journal-title":"Infect Dis Clin North Am."},{"key":"6201_CR23","doi-asserted-by":"publisher","unstructured":"Wade AJ, Doyle JS, Gane E, et al. Outcomes of Treatment for Hepatitis C in Primary Care, Compared to Hospital-based Care: A Randomized, Controlled Trial in People Who Inject Drugs. Clin Infect Dis. June 2019:1-7. doi:https:\/\/doi.org\/10.1093\/cid\/ciz546","DOI":"10.1093\/cid\/ciz546"},{"issue":"4","key":"6201_CR24","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.mcna.2018.02.007","volume":"102","author":"EJ Edelman","year":"2018","unstructured":"Edelman EJ, Oldfield BJ, Tetrault JM. Office-Based Addiction Treatment in Primary Care: Approaches That Work. Med Clin North Am. 2018;102(4):635-652. doi:https:\/\/doi.org\/10.1016\/j.mcna.2018.02.007","journal-title":"Med Clin North Am."},{"issue":"6","key":"6201_CR25","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1007\/s11606-019-04943-6","volume":"34","author":"ES Cole","year":"2019","unstructured":"Cole ES, DiDomenico E, Cochran G, et al. The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder. J Gen Intern Med. 2019;34(6):936-943. doi:https:\/\/doi.org\/10.1007\/s11606-019-04943-6","journal-title":"J Gen Intern Med."},{"issue":"2","key":"6201_CR26","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0002-9343(98)00194-6","volume":"105","author":"PG O\u2019Connor","year":"1998","unstructured":"O\u2019Connor PG, Oliveto AH, Shi JM, et al. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med. 1998;105(2):100-105. doi:https:\/\/doi.org\/10.1016\/S0002-9343(98)00194-6","journal-title":"Am J Med."},{"issue":"10","key":"6201_CR27","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/jvh.12393","volume":"22","author":"AA Artenie","year":"2015","unstructured":"Artenie AA, Jutras-Aswad D, Roy, et al. Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: Room for improvement. J Viral Hepat. 2015;22(10):792-799. doi:https:\/\/doi.org\/10.1111\/jvh.12393","journal-title":"J Viral Hepat."},{"issue":"6-7","key":"6201_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1081\/JA-100104092","volume":"36","author":"DD Chitwood","year":"2001","unstructured":"Chitwood DD, Sanchez J, Comerford M, McCoy CB. Primary preventive health care among injection drug users, other sustained drug users, and non-users. Subst Use Misuse. 2001;36(6-7):807-824.","journal-title":"Subst Use Misuse."},{"issue":"5","key":"6201_CR29","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1097\/ADM.0000000000000151","volume":"9","author":"R Ries","year":"2015","unstructured":"Ries R, Krupski A, West II, et al. Correlates of opioid use in adults with self-reported drug use recruited from public safety-net primary care clinics. J Addict Med. 2015;9(5):417-426. doi:https:\/\/doi.org\/10.1097\/ADM.0000000000000151","journal-title":"J Addict Med."},{"key":"6201_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drugalcdep.2019.02.030","volume":"200","author":"S Choi","year":"2019","unstructured":"Choi S, Biello KB, Bazzi AR, Drainoni M-L. Age differences in emergency department utilization and repeat visits among patients with opioid use disorder at an urban safety-net hospital: A focus on young adults. Drug Alcohol Depend. 2019;200:14-18. doi:https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.02.030","journal-title":"Drug Alcohol Depend."},{"issue":"16","key":"6201_CR31","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1001\/jama.2015.3474","volume":"313","author":"G D\u2019Onofrio","year":"2015","unstructured":"D\u2019Onofrio G, O\u2019Connor PG, Pantalon M V., et al. Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: A randomized clinical trial. JAMA. 2015;313(16):1636-1644. doi:https:\/\/doi.org\/10.1001\/jama.2015.3474","journal-title":"JAMA."},{"key":"6201_CR32","unstructured":"Herring A. CA Bridge Toolkit. Available at: https:\/\/www.bridgetotreatment.org\/. ."},{"key":"6201_CR33","unstructured":"A Matter of Urgency: Reducing Emergency Department Overuse.; 2010. Available at: https:\/\/www.nehi.net\/writable\/publication_files\/file\/nehi_ed_overuse_issue_brief_032610finaledits.pdf. Accessed December 23, 2019."},{"issue":"1","key":"6201_CR34","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/1472-6963-14-308","volume":"14","author":"D Nambiar","year":"2014","unstructured":"Nambiar D, Stoov\u00e9 M, Dietze P. A cross-sectional study describing factors associated with utilisation of GP services by a cohort of people who inject drugs. BMC Health Serv Res. 2014;14(1):308. doi:https:\/\/doi.org\/10.1186\/1472-6963-14-308","journal-title":"BMC Health Serv Res."},{"key":"6201_CR35","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.drugalcdep.2019.01.037","volume":"198","author":"DL Biancarelli","year":"2019","unstructured":"Biancarelli DL, Biello KB, Childs E, et al. Strategies used by people who inject drugs to avoid stigma in healthcare settings. Drug Alcohol Depend. 2019;198:80-86. doi:https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.037","journal-title":"Drug Alcohol Depend."},{"key":"6201_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugpo.2018.04.004","volume":"57","author":"CE Paquette","year":"2018","unstructured":"Paquette CE, Syvertsen JL, Pollini RA. Stigma at every turn: Health services experiences among people who inject drugs. Int J Drug Policy. 2018;57:104-110. doi:https:\/\/doi.org\/10.1016\/j.drugpo.2018.04.004","journal-title":"Int J Drug Policy."},{"issue":"17","key":"6201_CR37","doi-asserted-by":"publisher","first-page":"388","DOI":"10.15585\/mmwr.mm6817a3","volume":"68","author":"M Kariisa","year":"2019","unstructured":"Kariisa M, Scholl L, Wilson N, Seth P, Hoots B. Drug Overdose Deaths Involving Cocaine and Psychostimulants with Abuse Potential - United States, 2003-2017. Morb Mortal Wkly Rep. 2019;68(17):388-395. doi:https:\/\/doi.org\/10.15585\/mmwr.mm6817a3","journal-title":"Morb Mortal Wkly Rep"},{"key":"6201_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.drugalcdep.2019.03.014","volume":"200","author":"JA Barocas","year":"2019","unstructured":"Barocas JA, Wang J, Marshall BDL, et al. Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug Alcohol Depend. 2019;200:59-63. doi:https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.03.014","journal-title":"Drug Alcohol Depend."},{"issue":"10","key":"6201_CR39","doi-asserted-by":"publisher","first-page":"253","DOI":"10.15585\/mmwr.mm6810a6","volume":"68","author":"K Cranston","year":"2019","unstructured":"Cranston K, Alpren C, John B, et al. Notes from the Field: HIV Diagnoses Among Persons Who Inject Drugs \u2014 Northeastern Massachusetts, 2015\u20132018. Morb Mortal Wkly Rep. 2019;68(10):253-254. doi:https:\/\/doi.org\/10.15585\/mmwr.mm6810a6","journal-title":"Morb Mortal Wkly Rep"},{"issue":"12","key":"6201_CR40","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1089\/apc.2018.0126","volume":"32","author":"AR Bazzi","year":"2018","unstructured":"Bazzi AR, Biancarelli DL, Childs E, et al. Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention among People Who Inject Drugs. AIDS Patient Care STDS. 2018;32(12):529-537. doi:https:\/\/doi.org\/10.1089\/apc.2018.0126","journal-title":"AIDS Patient Care STDS."},{"key":"6201_CR41","doi-asserted-by":"publisher","DOI":"10.2307\/330063","volume-title":"Qualitative Research and Evaluation Methods","author":"MQ Patton","year":"2002","unstructured":"Patton MQ. Qualitative Research and Evaluation Methods. 3rd ed. Thousand Oaks, CA: Sage Publications; 2002. doi:https:\/\/doi.org\/10.2307\/330063","edition":"3"},{"key":"6201_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/sf\/70.4.1158","volume-title":"Selecting Ethnographic Informants","author":"JC Johnson","year":"1992","unstructured":"Johnson, JC; Arluke A. Selecting Ethnographic Informants. Newbury Park, CA: Sage Publications; 1992. doi:https:\/\/doi.org\/10.1093\/sf\/70.4.1158"},{"issue":"1","key":"6201_CR43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"1995","unstructured":"Guest G, Bunce A, Johnson L. How Many Interviews Are Enough? An Experiment with Data Saturation and Variability. Field methods. 1995;18(1):59-82. doi:https:\/\/doi.org\/10.1177\/1525822X05279903","journal-title":"Field methods."},{"key":"6201_CR44","doi-asserted-by":"crossref","DOI":"10.4159\/9780674028845","volume-title":"The Ecology of Human Development: Experiments by Nature and Design","author":"U Bronfenbrenner","year":"1979","unstructured":"Bronfenbrenner U. The Ecology of Human Development: Experiments by Nature and Design. Cambridge, MA: Harvard University Press; 1979."},{"issue":"Supplement 1","key":"6201_CR45","first-page":"S135","volume":"117","author":"S Galea","year":"2002","unstructured":"Galea S, Vlahov D. Social Determinants and the Health of Drug Users: Socioeconomic Status, Homelessness, and Incarceration. Public Health Rep. 2002;117(Supplement 1):S135-S145.","journal-title":"Public Health Rep"},{"key":"6201_CR46","doi-asserted-by":"publisher","unstructured":"Barocas JA, Brennan MB, Hull SJ, Stokes S, Fangman JJ, Westergaard RP. Barriers and facilitators of hepatitis C screening among people who inject drugs: a multi-city, mixed-methods study. Harm Reduct J. 2014;11(1). https:\/\/doi.org\/10.1186\/1477-7517-11-1","DOI":"10.1186\/1477-7517-11-1"},{"issue":"12","key":"6201_CR47","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1089\/apc.2010.0142","volume":"24","author":"D Swan","year":"2010","unstructured":"Swan D, Long J, Carr O, et al. Barriers to and Facilitators of Hepatitis C Testing, Management, and Treatment Among Current and Former Injecting Drug Users: A Qualitative Exploration. AIDS Patient Care STDS. 2010;24(12):753-762. doi:https:\/\/doi.org\/10.1089\/apc.2010.0142","journal-title":"AIDS Patient Care STDS."},{"issue":"1","key":"6201_CR48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12954-019-0286-6","volume":"16","author":"E Childs","year":"2019","unstructured":"Childs E, Assoumou SA, Biello KB, et al. Evidence-based and guideline-concurrent responses to narratives deferring HCV treatment among people who inject drugs. Harm Reduct J. 2019;16(1):14. doi:https:\/\/doi.org\/10.1186\/s12954-019-0286-6","journal-title":"Harm Reduct J."},{"issue":"1","key":"6201_CR49","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1747-597X-8-35","volume":"8","author":"K Lang","year":"2013","unstructured":"Lang K, Neil J, Wright J, Dell CA, Berenbaum S, El-Aneed A. Qualitative investigation of barriers to accessing care by people who inject drugs in Saskatoon, Canada: Perspectives of service providers. Subst Abus Treat Prev Policy. 2013;8(1):35. doi:https:\/\/doi.org\/10.1186\/1747-597X-8-35","journal-title":"Subst Abus Treat Prev Policy."},{"key":"6201_CR50","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.drugalcdep.2017.01.015","volume":"174","author":"A Reyre","year":"2017","unstructured":"Reyre A, Jeannin R, Largueche M, Moro MR, Baubet T, Taieb O. Overcoming professionals\u2019 challenging experiences to promote a trustful therapeutic alliance in addiction treatment: A qualitative study. Drug Alcohol Depend. 2017;174:30-38. doi:https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.01.015","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"6201_CR51","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1471-2296-11-79","volume":"11","author":"N Junod Perron","year":"2010","unstructured":"Junod Perron N, Dominic\u00e9 Dao M, Kossovsky MP, et al. Reduction of missed appointments at an urban primary care clinic: A randomised controlled study. BMC Fam Pract. 2010;11(1):79. doi:https:\/\/doi.org\/10.1186\/1471-2296-11-79","journal-title":"BMC Fam Pract."},{"key":"6201_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2019.09.003","volume":"107","author":"RL Snow","year":"2019","unstructured":"Snow RL, Simon RE, Jack HE, Oller D, Kehoe L, Wakeman SE. Patient experiences with a transitional, low-threshold clinic for the treatment of substance use disorder: A qualitative study of a bridge clinic. J Subst Abuse Treat. 2019;107:1-7. doi:https:\/\/doi.org\/10.1016\/j.jsat.2019.09.003","journal-title":"J Subst Abuse Treat."},{"key":"6201_CR53","doi-asserted-by":"publisher","unstructured":"Dombrowski JC, Ramchandani M, Dhanireddy S, Harrington RD, Moore A, Golden MR. The Max Clinic: Medical Care Designed to Engage the Hardest-to-Reach Persons Living with HIV in Seattle and King County, Washington. AIDS Patient Care STDS. 2018;32(4):149-156. doi:https:\/\/doi.org\/10.1089\/apc.2017.0313","DOI":"10.1089\/apc.2017.0313"},{"issue":"4","key":"6201_CR54","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/08897077.2013.797540","volume":"34","author":"SE Wakeman","year":"2013","unstructured":"Wakeman SE, Baggett M V., Pham-Kanter G, Campbell EG. Internal medicine residents training in substance use disorders: A survey of the quality of instruction and residents self-perceived preparedness to diagnose and treat addiction. Subst Abus. 2013;34(4):363-370. doi:https:\/\/doi.org\/10.1080\/08897077.2013.797540","journal-title":"Subst Abus."},{"issue":"4","key":"6201_CR55","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1080\/08897077.2018.1449047","volume":"39","author":"L Tesema","year":"2018","unstructured":"Tesema L, Marshall J, Hathaway R, et al. Training in office-based opioid treatment with buprenorphine in US residency programs: A national survey of residency program directors. Subst Abus. 2018;39(4):434-440. doi:https:\/\/doi.org\/10.1080\/08897077.2018.1449047","journal-title":"Subst Abus."},{"issue":"7","key":"6201_CR56","first-page":"537","volume":"49","author":"S Tong","year":"2017","unstructured":"Tong S, Sabo R, Aycock R, et al. Assessment of Addiction Medicine Training in Family Medicine Residency Programs: A CERA Study. Fam Med. 2017;49(7):537-543.","journal-title":"Fam Med."},{"issue":"4","key":"6201_CR57","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/08897077.2014.962722","volume":"36","author":"SE Wakeman","year":"2015","unstructured":"Wakeman SE, Pham-Kanter G, Baggett M V, Campbell EG. Medicine Resident Preparedness to Diagnose and Treat Substance Use Disorders: Impact of an Enhanced Curriculum. Subst Abus. 2015;36(4):427-433. doi:https:\/\/doi.org\/10.1080\/08897077.2014.962722","journal-title":"Subst Abus."},{"issue":"1","key":"6201_CR58","doi-asserted-by":"publisher","first-page":"56","DOI":"10.7326\/0003-4819-154-1-201101040-00008","volume":"154","author":"PG O\u2019Connor","year":"2011","unstructured":"O\u2019Connor PG, Nyquist JG, McLellan AT. Integrating addiction medicine into graduate medical education in primary care: The time has come. Ann Intern Med. 2011;154(1):56-59. doi:https:\/\/doi.org\/10.7326\/0003-4819-154-1-201101040-00008","journal-title":"Ann Intern Med."},{"issue":"3","key":"6201_CR59","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1080\/08897077.2018.1439800","volume":"39","author":"JL Taylor","year":"2018","unstructured":"Taylor JL, Rapoport AB, Rowley CF, Mukamal KJ, Stead W. An opioid overdose curriculum for medical residents: Impact on naloxone prescribing, knowledge, and attitudes. Subst Abus. 2018;39(3):371-376. doi:https:\/\/doi.org\/10.1080\/08897077.2018.1439800","journal-title":"Subst Abus."},{"key":"6201_CR60","unstructured":"Grayken Center for Addiction. Words Matter Pledge. Available at: https:\/\/www.bmc.org\/addiction\/reducing-stigma. Accessed March 26, 2020."},{"issue":"3","key":"6201_CR61","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.drugpo.2009.10.010","volume":"21","author":"JF Kelly","year":"2010","unstructured":"Kelly JF, Westerhoff CM. Does it matter how we refer to individuals with substance-related conditions? A randomized study of two commonly used terms. Int J Drug Policy. 2010;21(3):202-207. doi:https:\/\/doi.org\/10.1016\/j.drugpo.2009.10.010","journal-title":"Int J Drug Policy."},{"issue":"1","key":"6201_CR62","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.drugalcdep.2013.09.020","volume":"134","author":"C Bachireddy","year":"2014","unstructured":"Bachireddy C, Soule MC, Izenberg JM, Dvoryak S, Dumchev K, Altice FL. Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine. Drug Alcohol Depend. 2014;134(1):106-114. doi:https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.09.020","journal-title":"Drug Alcohol Depend."},{"key":"6201_CR63","unstructured":"Centers for Disease Control. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from CDC and the U.S. Department of Health and Human Services. MMWR Recomm Rep. 2012;61(RR-5):1-40."},{"key":"6201_CR64","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jsat.2015.06.010","volume":"60","author":"CT LaBelle","year":"2016","unstructured":"LaBelle CT, Han SC, Bergeron A, Samet JH. Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers. J Subst Abuse Treat. 2016;60:6-13. doi:https:\/\/doi.org\/10.1016\/j.jsat.2015.06.010","journal-title":"J Subst Abuse Treat."},{"key":"6201_CR65","doi-asserted-by":"publisher","first-page":"107527","DOI":"10.1016\/j.drugalcdep.2019.06.029","volume":"204","author":"R Ghertner","year":"2019","unstructured":"Ghertner R. U.S. trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018. Drug Alcohol Depend. 2019;204:107527. doi:https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.06.029","journal-title":"Drug Alcohol Depend"},{"key":"6201_CR66","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.ypmed.2018.06.005","volume":"114","author":"E Behar","year":"2018","unstructured":"Behar E, Bagnulo R, Coffin PO. Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review. Prev Med (Baltim). 2018;114:79-87. doi:https:\/\/doi.org\/10.1016\/j.ypmed.2018.06.005","journal-title":"Prev Med (Baltim)."},{"key":"6201_CR67","unstructured":"Syringe Service Program Laws. The Policy Surveillance Program, LawAtlas. Available at: http:\/\/lawatlas.org\/datasets\/syringe-services-programs-laws. Published August 1, 2019. Accessed March 26, 2020."},{"issue":"1","key":"6201_CR68","first-page":"122","volume":"81","author":"JD Rich","year":"2004","unstructured":"Rich JD, Mckenzie M, Macalino GE, et al. A Syringe Prescription Program to Prevent Infectious Disease and Improve Health of Injection Drug Users. J Urban Heal Bull New York Acad Med. 2004;81(1):122-134.","journal-title":"J Urban Heal Bull New York Acad Med."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06201-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-020-06201-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-020-06201-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T13:48:32Z","timestamp":1723556912000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-020-06201-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,11]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["6201"],"URL":"https:\/\/doi.org\/10.1007\/s11606-020-06201-6","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,11]]},"assertion":[{"value":"30 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Participants provided informed consent and received $25 for participating. The Brown and Boston University Institutional Review Boards approved all study protocols and provided a waiver of documentation of consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they do not have a conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}